Search and Filter
Results per Page:
Logistical hurdles prevent cancer patients from receiving care
From the Halpern Group, UW Division of Hematology and Oncology and the Fred Hutch Clinical Research Division
A COVID-19 Antiviral, Reconsidered: What modeling reveals about Molnupiravir
From the Schiffer Lab, Vaccine and Infectious Disease Division
Una segunda oportunidad para los linfocitos T-CAR en el osteosarcoma
Del laboratorio de Meshinchi, Departamento de Investigación Clínica y Departamento de Ciencias Traslacionales y Terapéutica
Dying cells signal the thymus to rebuild
From the Dudakov Lab, Translational Science and Therapeutics Division
Reading between the cells: How MRD details predict AML relapse
From the Walter Lab, Translational Science and Therapeutics Division
A promising new antibody treatment for a neglected respiratory virus
From the Boonyaratanakornkit Lab, Vaccine and Infectious Disease Division
Exposición de vulnerabilidades víricas para crear vacunas contra el cáncer
De los laboratorios Boonyaratanakornkit, Phipps, Pancera y McGuire, Departamento de Vacunas y Enfermedades Infecciosas
How chronic graft-versus-host disease unfolds ten years after transplant
From the Lee Lab, Clinical Research Division
A group retreat model for psilocybin therapy in cancer care
From Dr. Anthony Back and the Gooley Group, Clinical Research Division
Your gut may be talking to your brain
From the Robert Kaplan research group, Public Health Sciences Division
When breast cancer and heart disease intersect: racial differences in survivorship
From the Kerryn Reding research group, Public Health Sciences Division
Precancerous conditions make the stomach susceptible to bacterial infections
From the Salama Lab, Human Biology Division
A new biomarker for a form of muscular dystrophy could improve disease monitoring in patients
From the Tapscott lab, Human Biology Division
New glioblastoma models to study a devastating disease
From the Monnat Lab, University of Washington Departments of Laboratory Medicine and Pathology, Genome Sciences and the Cancer Consortium
Humanized mice and in vivo therapeutic production? This is not science fiction
From the Richard James Lab, Seattle Children’s Research Institute and the Cancer Consortium
Taming viral threats after lifesaving transplants
From the Boeckh Lab, Vaccine and Infectious Disease Division
Exposing viral vulnerabilities for targeted cancer vaccines
From the Boonyaratanakornkit, Phipps, Pancera, and McGuire Labs, Vaccine and Infectious Disease Division
Deep mutational scanning gives new insights into flu virus evolution
From the Bloom Lab, Basic Sciences Division
Histone H4 represses histone gene expression during the cell cycle
From the Henikoff Lab, Basic Sciences Division
Carrera contra reloj: Cronogramas más cortos mejoran las predicciones de la gripe
Del Laboratorio Bedford, Departamento de Vacunas y Enfermedades Infecciosas